In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d. Bikdeli B, Garcia DA. Ann Intern Med 2022 Feb 1. doi: 10.7326/J21-0019.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bikdeli B, Garcia DA. In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d. Ann Intern Med 2022 Feb 1. doi: 10.7326/J21-0019.
PMID: 35099994